UK markets open in 3 hours 27 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2200-0.1400 (-10.29%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.3600
Open1.3000
Bid1.1600 x 1000
Ask1.2900 x 1000
Day's range1.2000 - 1.3300
52-week range1.1500 - 4.8200
Volume151,434
Avg. volume142,168
Market cap32.261M
Beta (5Y monthly)2.04
PE ratio (TTM)N/A
EPS (TTM)-0.5940
Earnings date08 Nov 2022 - 14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.00
  • Business Wire

    DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

    MINNEAPOLIS, September 14, 2022--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Julie VanOrsdel Daves, MSHS, CCRP, as Senior Vice President (SVP), Clinical Development Operations. Ms. Daves, a recognized leader in managing global clinical studies, has significant experience in all phases of clinical development and will complement DiaMe

  • Business Wire

    DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference

    MINNEAPOLIS, September 06, 2022--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, its President and CEO will be participating at Lake Street Capital Market’s 6th Annual Best Ideas Growth (BIG6) Conference in New York, on September 14, 2022. Management will conduct one-on-one meetings with investors during the conference.

  • Business Wire

    DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results

    MINNEAPOLIS, August 10, 2022--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and released financial results for the quarter ended June 30, 2022. DiaMedica will host a conference call on Thursday, August 11, 2022, at 8:00AM Eastern Time / 7:00AM Central Time, to discuss its business update and second quarter financial results.